Felbamate urolithiasis
- PMID: 38129082
- PMCID: PMC10749159
- DOI: 10.1136/bcr-2022-253883
Felbamate urolithiasis
Abstract
Drug-induced nephrolithiasis is an important consideration in recurrent stone formers with polypharmacy. While felbamate nephrolithiasis has previously been published in the paediatric population, we present the oldest published case of a felbamate stone in an adult, a man in his 30s with Lennox-Gastaut syndrome. Even with moderate dosing, high drug serum levels can occur. Performing at least one stone analysis remains a critical component to care in these patients. Urologists should have a high index of suspicion for drug stone when stone analysis returns indeterminate characterisation in the absence of infection. Close communication with neurology is key to preventing recurrent stone disease.
Keywords: Epilepsy and seizures; Urological surgery.
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- Hanrahan B, Carson RP. Felbamate. 2021. Available: https://www.ncbi.nlm.nih.gov/books/NBK539799 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical